Lee SJ - Search Results

1

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma.

Lee BH, Park Y, Kim JH, Kang KW, Lee SJ, Kim SJ, Kim BS. Lee BH, et al. Among authors: lee sj. Front Oncol. 2021 Jun 14;11:669817. doi: 10.3389/fonc.2021.669817. eCollection 2021. Front Oncol. 2021. PMID: 34195077 Free PMC article.

2

PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model.

Lee BH, Park Y, Kim JH, Kang KW, Lee SJ, Kim SJ, Kim BS. Lee BH, et al. Among authors: lee sj. Sci Rep. 2020 Jul 28;10(1):12641. doi: 10.1038/s41598-020-69616-5. Sci Rep. 2020. PMID: 32724129 Free PMC article.

3

CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.

Lee SJ, Kang KW, Kim JH, Lee BH, Jung JH, Park Y, Hong SC, Kim BS. Lee SJ, et al. Among authors: lee bh. Stem Cells Dev. 2020 Feb 1;29(3):119-132. doi: 10.1089/scd.2019.0188. Epub 2020 Jan 6. Stem Cells Dev. 2020. PMID: 31808362

4

Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization.

Kang KW, Lee SJ, Kim JH, Lee BH, Kim SJ, Park Y, Kim BS. Kang KW, et al. Among authors: lee sj, lee bh. BMC Cancer. 2020 Jul 2;20(1):619. doi: 10.1186/s12885-020-07102-x. BMC Cancer. 2020. PMID: 32615949 Free PMC article.

5

Generation of normal induced pluripotent stem cell line KUMCi002-A from bone marrow CD34+ cells of patient with multiple myeloma disease having 13q deletion and IGH translocation.

Lee SJ, Kim JH, Kang KW, Lee BH, Kim BS. Lee SJ, et al. Among authors: lee bh. Stem Cell Res. 2020 Dec;49:102030. doi: 10.1016/j.scr.2020.102030. Epub 2020 Oct 15. Stem Cell Res. 2020. PMID: 33142253 Free article.

6

CXCR2, a novel target to overcome tyrosine kinase inhibitor resistance in chronic myelogenous leukemia cells.

Kim JH, Lee SJ, Kang KW, Lee BH, Park Y, Kim BS. Kim JH, et al. Among authors: lee sj, lee bh. Biochem Pharmacol. 2021 Aug;190:114658. doi: 10.1016/j.bcp.2021.114658. Epub 2021 Jun 17. Biochem Pharmacol. 2021. PMID: 34146540

7

Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.

Kim SJ, Lee SJ, Choi IY, Park Y, Choi CW, Kim IS, Yu W, Hwang HS, Kim BS. Kim SJ, et al. Among authors: lee sj. Eur J Haematol. 2008 Sep;81(3):177-84. doi: 10.1111/j.1600-0609.2008.01099.x. Epub 2008 May 27. Eur J Haematol. 2008. PMID: 18510703

8

Increased serum 90K and Galectin-3 expression are associated with advanced stage and a worse prognosis in diffuse large B-cell lymphomas.

Kim SJ, Lee SJ, Sung HJ, Choi IK, Choi CW, Kim BS, Kim JS, Yu W, Hwang HS, Kim IS. Kim SJ, et al. Among authors: lee sj. Acta Haematol. 2008;120(4):211-6. doi: 10.1159/000193223. Epub 2009 Jan 20. Acta Haematol. 2008. PMID: 19153476

9

Generation of an induced pluripotent stem cell line KUMCi001-A from CD34+ bone marrow cells of a patient with acute lymphoblastic leukemia using human placenta-derived cell conditioned medium.

Lee SJ, Kang KW, Kim JH, Park Y, Kim BS. Lee SJ, et al. Stem Cell Res. 2020 Jul 13;47:101913. doi: 10.1016/j.scr.2020.101913. Online ahead of print. Stem Cell Res. 2020. PMID: 32707488 Free article.

10

Supporting data on enhanced reprogramming of human CD34+ hematopoietic stem cells to induced pluripotent stem cells using human placenta-derived cell conditioned medium.

Lee SJ, Kim JH, Kang KW, Park Y, Kim BS. Lee SJ, et al. Data Brief. 2020 Aug 6;32:106140. doi: 10.1016/j.dib.2020.106140. eCollection 2020 Oct. Data Brief. 2020. PMID: 32904343 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,077 results

Search Page

Filters